688578 艾力斯
开盘竞价 10-26 09:30:00
资讯
新帖
简况
股市必读：艾力斯新发布《上海艾力斯医药科技股份有限公司自愿披露关于注射用AST1001临床试验申请获得FDA批准的公告》
证券之星 · 01:44
股市必读：艾力斯新发布《上海艾力斯医药科技股份有限公司自愿披露关于注射用AST1001临床试验申请获得FDA批准的公告》
艾力斯（688578）10月23日主力资金净卖出2397.57万元
证券之星 · 10-24 08:22
艾力斯（688578）10月23日主力资金净卖出2397.57万元
艾力斯最新公告：注射用AST1001临床试验申请获FDA批准
证券之星 · 10-23 20:39
艾力斯最新公告：注射用AST1001临床试验申请获FDA批准
艾力斯（688578）10月22日主力资金净卖出1902.27万元
证券之星 · 10-23
艾力斯（688578）10月22日主力资金净卖出1902.27万元
股市必读：艾力斯新发布《上海艾力斯医药科技股份有限公司关于以集中竞价交易方式首次回购公司股份的公告》
证券之星 · 10-21
股市必读：艾力斯新发布《上海艾力斯医药科技股份有限公司关于以集中竞价交易方式首次回购公司股份的公告》
司美格鲁肽注射液在华获批48小时配送新条件；艾力斯首次回购近1411万元｜医药早参
每日经济新闻 · 10-20
司美格鲁肽注射液在华获批48小时配送新条件；艾力斯首次回购近1411万元｜医药早参
艾力斯（688578）披露以集中竞价交易方式首次回购公司股份的公告，10月19日股价上涨1.48%
证券之星 · 10-19
艾力斯（688578）披露以集中竞价交易方式首次回购公司股份的公告，10月19日股价上涨1.48%
艾力斯（688578）披露以集中竞价交易方式回购股份的回购报告书，10月15日股价上涨3.25%
证券之星 · 10-15
艾力斯（688578）披露以集中竞价交易方式回购股份的回购报告书，10月15日股价上涨3.25%
艾力斯（688578）披露以集中竞价交易方式回购股份方案，10月14日股价上涨4.47%
证券之星 · 10-14
艾力斯（688578）披露以集中竞价交易方式回购股份方案，10月14日股价上涨4.47%
15家公司披露回购进展
同花顺 · 10-14
15家公司披露回购进展
艾力斯最新公告：拟1亿元-2亿元回购公司股份回购价格不超过150元/股
证券之星 · 10-13
艾力斯最新公告：拟1亿元-2亿元回购公司股份回购价格不超过150元/股
艾力斯全球化受阻
国际金融报 · 10-12
艾力斯全球化受阻
突曝利空！节后第一天，688578被砸20cm跌停，136家机构紧急调研！昨日仍放量大跌
同花顺 · 10-10
突曝利空！节后第一天，688578被砸20cm跌停，136家机构紧急调研！昨日仍放量大跌
突曝利空！节后第一天，688578被砸20cm跌停，136家机构紧急调研！昨日仍放量大跌
市场资讯 · 10-10
突曝利空！节后第一天，688578被砸20cm跌停，136家机构紧急调研！昨日仍放量大跌
科创50日内跌1.58%，艾力斯跌9.44％；半导体产业链下挫，康强电子、深科达跌逾4%
东方财富网 · 10-09
科创50日内跌1.58%，艾力斯跌9.44％；半导体产业链下挫，康强电子、深科达跌逾4%
艾力斯（688578）10月8日主力资金净卖出1.12亿元
证券之星 · 10-09
艾力斯（688578）10月8日主力资金净卖出1.12亿元
伏美替尼全球III期试验未达主要终点 艾力斯今日跌停
经济参考网 · 10-08
伏美替尼全球III期试验未达主要终点 艾力斯今日跌停
10月初回购热潮延续 上市公司真金白银传递信心
同花顺 · 10-08
10月初回购热潮延续 上市公司真金白银传递信心
伏美替尼海外III期折戟，艾力斯跌停，后续管线乏力
蓝鲸财经 · 10-08
伏美替尼海外III期折戟，艾力斯跌停，后续管线乏力
科创50日内跌幅达4.00% 艾力斯、源杰科技跌20%
股市直击 · 10-08
科创50日内跌幅达4.00% 艾力斯、源杰科技跌20%
加载更多
公司概况
公司名称：
上海艾力斯医药科技股份有限公司
所属行业：
医药制造业
上市日期：
2020-12-02
主营业务：
上海艾力斯医药科技股份有限公司的主营业务是肿瘤靶向创新药的研发、生产和营销。公司的主要产品是甲磺酸伏美替尼片、枸橼酸戈来雷塞片、普拉替尼胶囊。2025年，公司自主研发的1类小分子靶向药物甲磺酸伏美替尼片的核心化合物专利创新技术（吡啶胺基嘧啶衍生物、其制备方法及应用）已荣获国家知识产权局、世界知识产权组织联合颁授的第二十五届中国专利金奖。
发行价格：
22.73
{"stockData":{"symbol":"688578","market":"SH","secType":"STK","nameCN":"艾力斯","latestPrice":88.2,"timestamp":1792977705000,"preClose":88.12,"halted":0,"volume":0,"delay":0,"changeRate":0.0009,"floatShares":450000000,"shares":450000000,"eps":5.9526,"marketStatus":"开盘竞价","change":0.08,"latestTime":"10-26 09:30:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":88.2,"askSize":45,"bidPrice":88.2,"bidSize":45,"shortable":0,"etf":0,"ttmEps":5.9526,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792978200000},"marketStatusCode":1,"adr":0,"adjPreClose":88.12,"symbolType":"stock_kcb","openAndCloseTimeList":[[1792978200000,1792985400000],[1792990800000,1792998000000]],"highLimit":96.93,"lowLimit":79.31,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":450000000,"isCdr":false,"pbRate":4.69,"roa":"--","peRate":14.817055,"roe":"19.7%","epsLYR":4.86,"committee":0.285714,"marketValue":39690000000,"turnoverRate":0,"status":0,"floatMarketCap":39690000000},"requestUrl":"/m/hq/s/688578/","defaultTab":"news","newsList":[{"id":"2678136860","title":"股市必读：艾力斯新发布《上海艾力斯医药科技股份有限公司自愿披露关于注射用AST1001临床试验申请获得FDA批准的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2678136860","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678136860?lang=zh_cn&edition=full","pubTime":"2026-10-26 01:44","pubTimestamp":1792950255,"startTime":"0","endTime":"0","summary":"截至2026年10月23日收盘，艾力斯报收于88.12元，上涨4.28%，换手率1.69%，成交量7.63万手，成交额6.59亿元。公司公告汇总上海艾力斯医药科技股份有限公司自愿披露关于注射用AST1001临床试验申请获得FDA批准的公告上海艾力斯医药科技股份有限公司自主研发的注射用AST1001获得美国FDA批准开展临床试验。本次获批的临床试验为全球多中心、开放标签、剂量递增和扩展的I期试验，旨在评估药物的安全性、耐受性、药代动力学及初步抗肿瘤活性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600000511.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","09939","688578","BK0239","BK1515","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677903178","title":"艾力斯（688578）10月23日主力资金净卖出2397.57万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677903178","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677903178?lang=zh_cn&edition=full","pubTime":"2026-10-24 08:22","pubTimestamp":1792801328,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月23日收盘，艾力斯报收于88.12元，上涨4.28%，换手率1.69%，成交量7.63万手，成交额6.59亿元。近5日资金流向一览见下表：艾力斯融资融券信息显示，融资方面，当日融资买入4200.95万元，融资偿还6812.45万元，融资净偿还2611.5万元。艾力斯主营业务：专注于肿瘤治疗领域的创新药企业,目前已在非小细胞肺癌小分子靶向药领域构建了优势研发管线。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102400006938.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688578"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677922214","title":"艾力斯最新公告：注射用AST1001临床试验申请获FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2677922214","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677922214?lang=zh_cn&edition=full","pubTime":"2026-10-23 20:39","pubTimestamp":1792759175,"startTime":"0","endTime":"0","summary":"艾力斯(688578.SH)公告称，公司近日收到美国食品药品监督管理局(FDA)关于同意开展注射用AST1001用于治疗既往经标准治疗失败的局部晚期或转移性实体瘤成人患者临床试验的函告。该药品是公司自主研发的抗体偶联药物，由靶向EGFR和c-MET的双特异性抗体与拓扑异构酶Ⅰ抑制剂有效载荷-连接子偶联而成。本次获批是公司新药研发的阶段性成果，对近期业绩不会产生重大影响。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300041838.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688578"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677491814","title":"艾力斯（688578）10月22日主力资金净卖出1902.27万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677491814","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677491814?lang=zh_cn&edition=full","pubTime":"2026-10-23 08:20","pubTimestamp":1792714842,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月22日收盘，艾力斯报收于84.5元，下跌0.05%，换手率1.21%，成交量5.43万手，成交额4.6亿元。近5日资金流向一览见下表：艾力斯融资融券信息显示，融资方面，当日融资买入1854.26万元，融资偿还5934.42万元，融资净偿还4080.16万元。艾力斯主营业务：专注于肿瘤治疗领域的创新药企业,目前已在非小细胞肺癌小分子靶向药领域构建了优势研发管线。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300007458.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688578","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677112618","title":"股市必读：艾力斯新发布《上海艾力斯医药科技股份有限公司关于以集中竞价交易方式首次回购公司股份的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2677112618","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677112618?lang=zh_cn&edition=full","pubTime":"2026-10-21 01:21","pubTimestamp":1792516868,"startTime":"0","endTime":"0","summary":"公司公告汇总上海艾力斯医药科技股份有限公司关于以集中竞价交易方式首次回购公司股份的公告2026年10月19日，公司通过集中竞价交易方式首次回购股份169,956股，占公司总股本的0.038%；回购最高价83.97元/股，最低价81.61元/股；已支付金额14,110,147.52元。上海艾力斯医药科技股份有限公司关于回购股份事项前十名股东和前十名无限售条件股东的公告公司于2026年10月13日召开董事会，审议通过以集中竞价交易方式回购公司股份的方案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100001470.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","09939","688578","BK0239","BK1161","BK1574","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676634627","title":"司美格鲁肽注射液在华获批48小时配送新条件；艾力斯首次回购近1411万元｜医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2676634627","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676634627?lang=zh_cn&edition=full","pubTime":"2026-10-20 07:00","pubTimestamp":1792450857,"startTime":"0","endTime":"0","summary":"｜2026年10月20日星期二｜NO.1司美格鲁肽注射液在华获批48小时配送新条件10月19日，诺和诺德宣布，中国国家药监局已批准更新司美格鲁肽注射液（商品名：诺和盈?）产品信息：在分发给患者的过程中，首次开启前，诺和盈?可在2℃～30℃的温度下储存最长48小时。此次批准使诺和盈?成为中国首个且唯一具备这一配送灵活性的GLP-1体重管理治疗方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610203900358225.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610203900358225.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","09939","BK1574","159938","688578","BK1515","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676068454","title":"艾力斯（688578）披露以集中竞价交易方式首次回购公司股份的公告，10月19日股价上涨1.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2676068454","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676068454?lang=zh_cn&edition=full","pubTime":"2026-10-19 22:33","pubTimestamp":1792420399,"startTime":"0","endTime":"0","summary":"截至2026年10月19日收盘，艾力斯报收于83.0元，较前一交易日上涨1.48%，最新总市值为373.5亿元。该股当日开盘80.51元，最高83.98元，最低80.51元，成交额达5.57亿元，换手率为1.5%。近日，上海艾力斯医药科技股份有限公司发布《关于以集中竞价交易方式首次回购公司股份的公告》。公告显示，2026年10月19日，公司通过集中竞价交易方式首次回购股份169,956股，占公司总股本的0.038%，回购最高价83.97元/股，最低价81.61元/股，已支付金额14,110,147.52元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900030175.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688578"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675157533","title":"艾力斯（688578）披露以集中竞价交易方式回购股份的回购报告书，10月15日股价上涨3.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675157533","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675157533?lang=zh_cn&edition=full","pubTime":"2026-10-15 22:26","pubTimestamp":1792074378,"startTime":"0","endTime":"0","summary":"截至2026年10月15日收盘，艾力斯报收于84.46元，较前一交易日上涨3.25%，最新总市值为380.07亿元。该股当日开盘80.8元，最高84.88元，最低80.45元，成交额达8.59亿元，换手率为2.28%。近日，上海艾力斯医药科技股份有限公司发布《关于以集中竞价交易方式回购股份的回购报告书》。公告显示，公司拟以集中竞价交易方式回购股份，回购资金总额不低于10,000万元且不超过20,000万元，资金来源为自有资金，回购价格不超过150.00元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500039503.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688578","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675170213","title":"艾力斯（688578）披露以集中竞价交易方式回购股份方案，10月14日股价上涨4.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675170213","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675170213?lang=zh_cn&edition=full","pubTime":"2026-10-14 17:27","pubTimestamp":1791970062,"startTime":"0","endTime":"0","summary":"截至2026年10月14日收盘，艾力斯报收于81.8元，较前一交易日上涨4.47%，最新总市值为368.1亿元。该股当日开盘78.62元，最高83.55元，最低78.21元，成交额达8.89亿元，换手率为2.43%。上海艾力斯医药科技股份有限公司于2026年10月14日发布《关于以集中竞价交易方式回购股份方案的公告》。公告显示，公司拟以集中竞价交易方式回购股份，回购资金总额不低于10,000.00万元且不超过20,000.00万元，资金来源为自有资金，回购价格不超过150.00元/股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400029370.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688578","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675039608","title":"15家公司披露回购进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2675039608","media":"同花顺","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675039608?lang=zh_cn&edition=full","pubTime":"2026-10-14 08:56","pubTimestamp":1791939360,"startTime":"0","endTime":"0","summary":"10月14日，15家公司发布股票回购相关进展。其中，4家公司首次披露股票回购预案，2家公司回购方案获股东大会通过，4家公司披露股票回购实施进展，5家公司回购方案已实施完毕。从首次披露回购 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261014/c680662310.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261014/c680662310.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["LU2778985437.USD","LU0572939691.SGD","LU1366334651.USD","LU0898667661.SGD","BK0196","LU1568876335.HKD","LU2289578879.USD","BK0026","IE00B067MR52.USD","688578","LU1568876251.USD","IE00BZ08YR35.GBP","BK0070","301132","LU0831103253.SGD","002481","BK0027","600167","000333","LU2097828631.EUR","BK0188","BK0271","000415","LU0955623706.USD","300602","LU1675838814.USD","BK0028","LU2506952253.HKD","BK0077","LU2476274308.USD","605020","LU0228659784.USD","LU2097828557.USD","IE00BZ08YT58.USD","LU1146622755.USD","LU2097828714.EUR","BK0139","IE00B031HY20.USD","LU0784639295.USD","LU0269904917.USD","LU1655091459.SGD","LU1997245177.USD","001230","LU0405327148.USD","LU1064130708.USD","000711","IE00BZ08YS42.EUR","002947","LU0052750758.USD","IE00BPRC5H50.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675356533","title":"艾力斯最新公告：拟1亿元-2亿元回购公司股份回购价格不超过150元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2675356533","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675356533?lang=zh_cn&edition=full","pubTime":"2026-10-13 19:01","pubTimestamp":1791889315,"startTime":"0","endTime":"0","summary":"艾力斯(688578.SH)公告称，公司董事会审议通过回购股份方案，拟以自有资金通过集中竞价交易方式回购部分A股股票，回购价格不超过150元/股，回购资金总额不低于1亿元且不超过2亿元，回购股份将用于员工持股计划或股权激励。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300033066.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688578","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674221118","title":"艾力斯全球化受阻","url":"https://stock-news.laohu8.com/highlight/detail?id=2674221118","media":"国际金融报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674221118?lang=zh_cn&edition=full","pubTime":"2026-10-12 15:01","pubTimestamp":1791788498,"startTime":"0","endTime":"0","summary":"艾力斯全球化受阻","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610123892641367.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610123892641367.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0239","688578"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674189622","title":"突曝利空！节后第一天，688578被砸20cm跌停，136家机构紧急调研！昨日仍放量大跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2674189622","media":"同花顺","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674189622?lang=zh_cn&edition=full","pubTime":"2026-10-10 15:04","pubTimestamp":1791615840,"startTime":"0","endTime":"0","summary":"【导读】136家机构及个人投资者共计191人调研艾力斯虽然国庆节后第一周只有10月8日、9日两个交易日，但机构调研脚步不停。10月8日节后上班第一天，就有136家机构于下午收盘后调研艾力斯。而 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261010/c680550852.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261010/c680550852.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["688578","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674896224","title":"突曝利空！节后第一天，688578被砸20cm跌停，136家机构紧急调研！昨日仍放量大跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2674896224","media":"市场资讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674896224?lang=zh_cn&edition=full","pubTime":"2026-10-10 15:02","pubTimestamp":1791615720,"startTime":"0","endTime":"0","summary":"10月8日节后上班第一天，就有136家机构于下午收盘后调研艾力斯。而艾力斯股价当天低开后快速20%跌停。然而，10月8日开盘，艾力斯股价大幅低开后快速封住20%跌停，龙虎榜数据显示，当天3家机构席位合计卖出超5000万元，1家机构席位买入1121万元。10月9日收盘，艾力斯股价跌7.57%，报82.5元，成交额大幅放量；最新总市值为371.3亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/roll/2026-10-10/doc-iniutqmm7355301.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","688578"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674878528","title":"科创50日内跌1.58%，艾力斯跌9.44％；半导体产业链下挫，康强电子、深科达跌逾4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674878528","media":"东方财富网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674878528?lang=zh_cn&edition=full","pubTime":"2026-10-09 09:58","pubTimestamp":1791511132,"startTime":"0","endTime":"0","summary":"10月9日，A股三大指数集体低开，沪指低开0.21%，深成指低开0.51%，创业板指低开0.50%。盘面上，光芯片、覆铜板、玻纤板块调整；海运、油气、黄金板块走强。科创50日内跌幅1.58%，成分股中，艾力斯跌9.44％，国博电子跌近4%，源杰科技、生益电子跌逾3％，华丰科技跌2.03％。CPO、光芯片概念股续跌，沃格光电、东山精密、长光华芯跌幅居前。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://stock.eastmoney.com/news/1407,202610093890702040.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/news/1407,202610093890702040.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["BK0077","BK0102","BK0081","BK1610","03191","KSTR","BK0239","688328","BK0214","002119","TTEQ","BK0251","688578"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674895188","title":"艾力斯（688578）10月8日主力资金净卖出1.12亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674895188","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674895188?lang=zh_cn&edition=full","pubTime":"2026-10-09 08:25","pubTimestamp":1791505504,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月8日收盘，艾力斯报收于89.26元，下跌20.0%，跌停，换手率1.47%，成交量6.63万手，成交额5.98亿元。近5日资金流向一览见下表：艾力斯融资融券信息显示，融资方面，当日融资买入6969.99万元，融资偿还9283.79万元，融资净偿还2313.8万元。艾力斯主营业务：专注于肿瘤治疗领域的创新药企业,目前已在非小细胞肺癌小分子靶向药领域构建了优势研发管线。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900006060.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688578"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673300655","title":"伏美替尼全球III期试验未达主要终点 艾力斯今日跌停","url":"https://stock-news.laohu8.com/highlight/detail?id=2673300655","media":"经济参考网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673300655?lang=zh_cn&edition=full","pubTime":"2026-10-08 23:07","pubTimestamp":1791472057,"startTime":"0","endTime":"0","summary":"国庆假期后首个交易日，科创板上市公司艾力斯（688578.SH）股价跌停。截至10月8日收盘，艾力斯报89.26元/股，下跌20.00%，成交额5.98亿元，换手率1.47%，总市值401.7亿元。消息面上，公司前一日晚间发布公告称，核心产品甲磺酸伏美替尼片（以下简称“伏美替尼”）的一项全球关键性III期临床试验未达到主要研究终点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610083890003560.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610083890003560.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0239","688578"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673704190","title":"10月初回购热潮延续 上市公司真金白银传递信心","url":"https://stock-news.laohu8.com/highlight/detail?id=2673704190","media":"同花顺","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673704190?lang=zh_cn&edition=full","pubTime":"2026-10-08 21:12","pubTimestamp":1791465120,"startTime":"0","endTime":"0","summary":" 进入10月份，A股上市公司回购延续9月份活跃态势。10月7日晚间至10月8日晚间，多家上市公司发布回购相关公告。 上海艾力斯医药科技股份有 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261008/c680494567.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261008/c680494567.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["301308","LU2097828474.EUR","LU0509642566.USD","LU2476274308.USD","LU0634319403.HKD","LU0210527791.USD","IE0008368411.USD","LU0469268626.HKD","LU0572939691.SGD","LU0320764599.SGD","LU2177674079.SGD","003012","LU1794554557.SGD","BK0061","LU0823437842.USD","LU1961090484.USD","LU1366334651.USD","LU0890818403.SGD","LU0784639295.USD","LU1781817850.SGD","300308","BK0188","LU0082770016.USD","LU0396098781.USD","LU0359201612.USD","LU0327786744.USD","HK0000306685.HKD","09976","LU1997244956.HKD","LU1655091616.SGD","BK0196","LU1934453819.USD","SGXZ49509284.SGD","BK0012","IE0032834883.USD","IE0031814852.USD","LU1580142542.USD","603262","BK0183","BK0239","LU2097828714.EUR","LU0862451753.SGD","BK0175","IE0034224299.USD","LU0620787316.HKD","LU1255011170.USD","LU1146622755.USD","LU0210526637.USD","LU0269904917.USD","SGXZ81163826.USD","LU0264606111.USD","LU1568876335.HKD","LU0348827113.USD","LU0051755006.USD","000333","LU1675838814.USD","BK0077","LU0791590937.USD","LU2495084118.USD","LU0898667661.SGD","LU1251922891.USD","LU2289578879.USD","LU0862451837.USD","LU0456827905.SGD","SG9999011746.SGD","BK0214","LU0531971595.HKD","LU0052750758.USD","IE00B031J352.USD","BK0224","LU0405327494.USD","LU1366334578.USD","LU1770034418.SGD","IE00BYQNZ168.SGD","LU2580892789.USD","IE00B12V2V27.USD","LU0231483743.USD","LU2399975544.HKD","IE00B5MMRT66.SGD","IE00BZ08YR35.GBP","IE00BPRC5H50.USD","LU0955623706.USD","LU2008162690.USD","LU0828238088.HKD","IE00BZ08YT58.USD","LU1064131003.USD","LU1206782309.USD","LU1048484197.HKD","LU1808992512.USD","LU0164865239.USD","LU0955669360.SGD","LU1303224171.USD","LU0082770016.SGD","IE0003795394.USD","LU0831103253.SGD","LU0117844026.USD","LU2097828805.USD","LU1720050803.USD","BK0167","06166","LU1997245094.SGD","LU2097828557.USD","IE00BYTNYN87.SGD","LU0359202008.SGD","LU2213484517.USD","LU2506952253.HKD","LU0540923850.HKD","IE00B067MR52.USD","IE00B8L5B284.USD","HK0000320264.USD","IE0032431581.USD","LU0871576103.HKD","LU2778985437.USD","00300","LU0572940350.SGD","IE0009570106.USD","IE00B543WZ88.USD","LU2476274720.SGD","LU1979443071.USD","IE00B8HQ1Z84.USD","IE0008368742.USD","IE0005HP3H50.USD","LU0348825331.USD","LU1064130708.USD","BK0226","LU0228659784.USD","LU1997245177.USD","LU0955648018.USD","LU2148510915.USD","BK0070","LU0417516902.SGD","IE00B031HW06.USD","BK0026","LU0572944931.SGD","LU0348735423.USD","LU2097828631.EUR","IE00B97KM107.HKD","LU0561508036.HKD","LU1568876251.USD","IE00B29SXG58.USD","LU0164939612.USD","LU2580892862.HKD","LU0039217434.USD","LU0593848301.USD","688578","LU0405327148.USD","IE00B031HY20.USD","LU1655091459.SGD","LU0417516738.SGD","BK0187","IE0003851619.USD","LU0456842615.SGD","LU0791591158.USD","LU0359201885.HKD","LU1130305938.SGD","BK0028","603083","LU1820825898.SGD","LU1039395188.USD","HK0000306701.USD","LU0708995583.HKD","HK0000320223.HKD","BK0235","03308","IE00BKZH1Z71.USD","LU1719994722.HKD","LU1023057109.AUD","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673228480","title":"伏美替尼海外III期折戟，艾力斯跌停，后续管线乏力","url":"https://stock-news.laohu8.com/highlight/detail?id=2673228480","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673228480?lang=zh_cn&edition=full","pubTime":"2026-10-08 16:20","pubTimestamp":1791447628,"startTime":"0","endTime":"0","summary":"根据艾力斯公告指出，公司正与ArriVent共同评估完整数据集，以确定后续开发方案。不过，伏美替尼还在开展另一项全球III期研究ALPACCA，针对的是EGFR PACC突变一线NSCLC患者，该适应症是否能突围或许是该款药物能否成功出海的重要决定因素。此外，2026年2月，伏美替尼适用于EGFR20外显子插入突变二线治疗适应症成功获批上市；2026年4月，伏美替尼适用于EGFR PACC突变一线治疗适应症III期临床试验IND获得国家药品监督管理局批准。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1791447331315786552","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["688578","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673238480","title":"科创50日内跌幅达4.00% 艾力斯、源杰科技跌20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673238480","media":"股市直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673238480?lang=zh_cn&edition=full","pubTime":"2026-10-08 13:30","pubTimestamp":1791437400,"startTime":"0","endTime":"0","summary":"专题：A股节后有望“开门红” 中期走势不悲观炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！10月8日，科创50日内跌幅达4.00%，成分股中，艾力斯跌20.00%，源杰科技跌20.00%，传音控股跌13.57%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/roll/2026-10-08/doc-iniunvxf4365350.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688498","SGXZ81163826.USD","BK0239","BK0214","KSTR","688578","SGXZ49509284.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1792977711424,"stockEarnings":[{"period":"1week","weight":0.0774},{"period":"1month","weight":-0.2162},{"period":"3month","weight":-0.2568},{"period":"6month","weight":-0.0641},{"period":"1year","weight":-0.1504},{"period":"ytd","weight":-0.1435}],"compareEarnings":[{"period":"1week","weight":-0.0069},{"period":"1month","weight":-0.0625},{"period":"3month","weight":-0.0324},{"period":"6month","weight":-0.0954},{"period":"1year","weight":-0.0591},{"period":"ytd","weight":-0.0701}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海艾力斯医药科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"21039人(较上一季度增加3.72%)","perCapita":"21388股","listingDate":"2020-12-02","address":"上海市浦东新区周浦镇凌霄花路268号","registeredCapital":"45000万元","survey":" 上海艾力斯医药科技股份有限公司的主营业务是肿瘤靶向创新药的研发、生产和营销。公司的主要产品是甲磺酸伏美替尼片、枸橼酸戈来雷塞片、普拉替尼胶囊。2025年，公司自主研发的1类小分子靶向药物甲磺酸伏美替尼片的核心化合物专利创新技术（吡啶胺基嘧啶衍生物、其制备方法及应用）已荣获国家知识产权局、世界知识产权组织联合颁授的第二十五届中国专利金奖。","listedPrice":22.73},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"艾力斯(688578)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供艾力斯(688578)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"艾力斯,688578,艾力斯股票,艾力斯股票老虎,艾力斯股票老虎国际,艾力斯行情,艾力斯股票行情,艾力斯股价,艾力斯股市,艾力斯股票价格,艾力斯股票交易,艾力斯股票购买,艾力斯股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"艾力斯(688578)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供艾力斯(688578)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}